Sutton Wealth Advisors’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-38
Closed -$523 1612
2022
Q4
$523 Sell
38
-660
-95% -$10.1K ﹤0.01% 1482
2022
Q3
$13.3K Buy
698
+660
+1,737% +$12K 0.01% 800
2022
Q2
$580 Sell
38
-914
-96% -$13.5K ﹤0.01% 1423
2022
Q1
$19.4K Buy
952
+365
+62% +$7.43K 0.01% 716
2021
Q4
$17.1K Buy
+587
New +$16.8K 0.01% 757

Other funds holding CDMO

Sutton Wealth Advisors's CDMO Position: Q1 2023 in Review

Sutton Wealth Advisors sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2023, closing a stake of 38 shares — an estimated $523 sold.

Sutton Wealth Advisors first reported a position in CDMO in Q4 2021 and held it in 5 quarters. The position peaked at $19.4K in Q1 2022. 168 funds tracked by Wall St. Rank hold CDMO as of Q1 2023.

  • Sutton Wealth Advisors reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Sutton Wealth Advisors sold 38 Avid Bioservices, Inc. Common Stock shares in Q1 2023, an estimated $523.
  • Sutton Wealth Advisors first reported a position in Avid Bioservices, Inc. Common Stock in Q4 2021 and held it in 5 quarters.
  • Sutton Wealth Advisors's Avid Bioservices, Inc. Common Stock position peaked at $19.4K in Q1 2022.
  • 168 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2023.

Based on Sutton Wealth Advisors's 13F filing for Q1 2023, filed 7 Nov 2023.